Clinical Trial Update: The German ADPKD Tolvaptan Treatment Registry

View source ↗

Summary

A German registry sponsored by the University of Cologne is recruiting participants to document tolvaptan treatment in autosomal dominant polycystic kidney dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Polycystic Kidney Disease

Drugs mentioned

• tolvaptan (tolvaptan)

Snippet

Sponsor: University of Cologne | Conditions: ADPKD (Autosomal Dominant Polycystic Kidney Disease) | Status: RECRUITING